Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-10-14 3:41 pm Purchase | 2025-10-07 | 13G | Crescent Biopharma, Inc. CBIO | 1Globe Capital LLC | 1,425,432 10.300% | 528,720 (+58.96%) | Filing History |
| 2025-08-20 5:20 pm Purchase | 2025-08-13 | 13G | Crescent Biopharma, Inc. CBIO | 1Globe Capital LLC | 896,712 6.450% | 896,712 (New Position) | Filing History |
| 2025-07-07 9:41 pm Unchanged | 2025-07-07 | 13D | SINOVAC BIOTECH LTD SVA | 1Globe Capital LLC | 18,515,315 32.300% | 0 (Unchanged) | Filing History |
| 2025-07-03 9:47 pm Unchanged | 2025-06-27 | 13D | SINOVAC BIOTECH LTD SVA | 1Globe Capital LLC | 18,515,315 32.300% | 0 (Unchanged) | Filing History |
| 2025-07-01 10:56 am Unchanged | 2025-06-27 | 13D | SINOVAC BIOTECH LTD SVA | 1Globe Capital LLC | 18,515,315 32.300% | 0 (Unchanged) | Filing History |